科研之友
微信
新浪微博
Facebook
分享链接
摘要
Cognitive deficits are prevalent in hemodialysis (HD) patients. Vitamin D deficiency and vitamin D receptor (VDR) gene single nucleotide polymorphism (SNPs) have been linked to both neurodegeneration (ND) and neuroprotection, respectively. Autoantibodies (Ab) to myelin basic protein (MBP), glial fibrillary acidic protein (GFAP), and neurofilament (NF) triplet proteins arise secondary to nervous system (NS) damage providing a means to assess neurological injury. Characterization of Ab biomarkers of NS damage in HD patients, their association with VDR SNPs, and nutritional vitamin D (NVD) therapy was performed. VDR genotypes, cytokines, and Ab biomarkers to NS proteins in HD subjects receiving ergocalciferol (n?=?40) were compared with nonusers (n?=?71). Interleukin-6 (IL-6), tumor necrosis factor-a (TNF-a), and immunoglobulin G (IgG) titers against NFs, GFAP, and MBP were measured by immunoassay. Subjects were genotyped for VDR SNPs BsmI (rs1544410) and FokI (rs2228570). Subjects (age 63.3?+/-?16.1 years, 66% male) who were C allele carriers of BsmI had higher values of NF-68 antibody titers (p?=?0.027). Ergocalciferol users (n?=?40) compared with nonusers (n?=?71) had lower Ab titers to NS proteins; however, only antiNF-160 and anti-MBP titers were significantly (p?%26lt;?0.05) higher. IgG against NS proteins in HD patients suggests neuronal and glial insult and a relationship with VDR alleles. NVD may provide some neuroprotection, indicated by antiNF-160 and anti-MBP, which was markedly lowered in ergocalciferol patients. This preliminary study suggests that Ab detection may be useful in monitoring ND and the potential of NVD for neuroprotection in HD patients.
- 出版日期2013-1
